SMi Group’s 4th Annual Conference: Ophthalmic Drugs

SMi Group’s 4th Annual Conference: Ophthalmic Drugs

22nd – 23rd November 2021at the Holiday Inn Kensington Forum, London ,UK
Exploring the unique challenges and latest breakthroughs in ocular drug development and delivery

Now is the time to secure your place to avoid disappointment.

Visit the website at www.ophthalmicdrugs.com or contact Alia Malick, Director by emailing amalick@smi-online.co.uk or call +44 (0) 207 827 6168

Hear more from Daniel Chung, Chief Medical Officer, on Sparing Vision

At 09:10 on day two Daniel will be opening the conference with his presentation on:

Ocular Gene Therapy
• The basic tenets of ocular gene therapy
o What we have learned
o What we still need to know
• Update on current ocular gene therapyC
o Current genotypes under investigation
o Who’s in clinical trials
o What’s on the market
• The future of ocular gene therapy
o Delivery systems
o Gene agnostic approaches